Lisa Rydén
41 – 50 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
-
Mark
Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data
(
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
(
- Contribution to journal › Article
- 2020
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
(
- Contribution to journal › Article
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
(
- Contribution to journal › Article
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18(
- Contribution to journal › Published meeting abstract
-
Mark
The generalisability of randomised clinical trials : an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
(
- Contribution to journal › Article
-
Mark
Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment : Study protocol for the ReScreen randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study
(
- Contribution to journal › Article